Repurposing medicinal compounds for blood cancer treatment-Reference-Cited by-同舟云学术

Repurposing medicinal compounds for blood cancer treatment

Published:2015-06-07 Issue:8 Volume:94 Page:1267-1276
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

McCabe Bronagh,Liberante Fabio,Mills Ken I.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-015-2412-1/fulltext.html

Reference46 articles.

1. Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673–683

2. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2):151–185

3. Report to the President of propelling innovation in drug discovery, development and evaluation. 2012. The President’s Council of Advisors on Science and Technology

4. Mullard A (2013) FDA drug approvals. Nat Rev Drug Discov 12(2):87–90

5. U.S. Food and Drug Administration CfDEaR. Novel New Drugs 2014 Summary

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular mechanisms underlying the potential of betulinic acid in cancer prevention and treatment;Phytomedicine;2024-09

2. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches;Journal of Medical Virology;2023-03-31

3. Anticancer Potential and Molecular Mechanisms of Cinnamaldehyde and Its Congeners Present in the Cinnamon Plant;Physiologia;2023-03-30

4. Drug Repurposing for Hematological Malignancies;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023

5. Applications of dihydropyrimidinone derivatives on blood cancer and colon cancer;Dihydropyrimidinones as Potent Anticancer Agents;2023